| Literature DB >> 27501695 |
Shunsuke Endo1,2, Norihiko Ikeda3,4, Takashi Kondo3,5, Jun Nakajima3,6, Haruhiko Kondo3,7, Kohei Yokoi3,8, Masayuki Chida3,9, Masami Sato3,10, Shinichi Toyooka3,11, Koichi Yoshida3,4, Yoshinori Okada3,12, Yukio Sato3,13, Meinoshin Okumura14,15, Munetaka Masuda14,16, Koji Chihara17,18,19, Hiroaki Miyata20,21.
Abstract
OBJECTIVES: A national clinical database (NCD) adopted an "Internet-based collection" in 2011. An NCD specializing in chest surgery was launched based on the NCD system in 2014. The system was linked to the board certification as the second level in the hierarchy of the specialty of chest surgery and accreditation of educational institutions for chest surgery. Here, we report the status of the NCD for chest surgery in 2014 and clarified its registration rate and its accuracy.Entities:
Keywords: Board certification; Chest surgery; Database; Internet; Nationwide survey
Mesh:
Year: 2016 PMID: 27501695 PMCID: PMC5035318 DOI: 10.1007/s11748-016-0697-1
Source DB: PubMed Journal: Gen Thorac Cardiovasc Surg ISSN: 1863-6705
Fig. 1First step of NCD registration. The essential items required for the first step of NCD registration. The postal code of the patient must be inputted. Surgeons and assistants can be identified by the license number registered by the Japanese Surgical Society
Fig. 2Chart of input items for perioperative information. In the first step of the registry process for chest surgery, the operation is categorized as a surgical thoracic disease. All input items, which are displayed according to the thoracic disease, must be filled out. Perioperative evaluations include common items and unique items according to the categorized disease. Finally, discharge information is inputted. These clinical data in relation to chest surgery were inputted until the completion of data registration without alerts showing inputting mistakes
Preoperative information
| Height, weight and performance status |
| Pulmonary function test (VC*1, FVC*2, FEV1.0*3) |
| Smoking history and status |
| Anticancer treatment (if the disease is a thoracic malignancy)*4 |
| Comorbidity |
| Coronary artery disease*5 |
| Anticancer treatment within the past 5 years |
| Disease of the central nervous system*6 |
| Diabetes mellitus*7, hemodialysis, anemia*8 |
| Interstitial pneumonia*9, Liver failure*10 |
| Autoimmune disease*5, arrhythmia*6, hypertension*6 |
| Other (supplementary explanation) |
| Clinical TNM staging for lung cancer |
1Vital capacity
2Forced vital capacity
3Forced expiratory volume in 1 s
4Chemotherapy, radiotherapy, chemoradiotherapy, other
5Required treatment or previous treatment
6Required treatment
7Required treatment and supplementary explanation
8Hemoglobin concentration ≤8.0 g/dL
9Interstitial pneumonia shadow on computed tomography of the chest
10Child–Turcotte classification B or C
Operative information
| Operative time, blood loss, transfusion, intraoperative accident |
| Approach (open, VATS, robot) |
| Procedure (main procedure, nodal dissection, combined resection) |
| Supplement |
| Number of cartilages stapled, energy device (except electric cautery), fibrin glue, extracorporeal life support |
| Lung cancer |
| Detailed VATS approach: number of access ports, maximum diameter of the wound |
| Histology, pathologic TNM staging |
| Thoracic neoplasm (other than lung cancer) |
| Histology |
| Pneumothorax |
| Surgical procedure, buttress sheet |
Postoperative events
| Pulmonary |
| Prolonged air leak*1 |
| Atelectasis*2 |
| Pneumonia*3 |
| Acute exacerbated interstitial pneumonia |
| Respiratory failure*4 |
| ARDS*5 |
| Bronchopleural fistulae |
| Pulmonary emboli |
| Cardiovascular |
| Arrhythmia*6 |
| Myocardial infarction |
| Congestive heart failure*6 |
| Neurology |
| Cerebral hemorrhage |
| Cerebral infarction |
| Hoarseness |
| Delirium*6 |
| Infection |
| Empyema*7 |
| Mediastinitis*7 |
| Wound infection*7 |
| Miscellaneous |
| Redo-surgery within 24 h |
| Bleeding*8 |
| Chylothorax |
| Renal failure*9 |
| Liver failure*6 |
| Other (supplementary explanation) |
1Air leak >6 days duration or required treatment
2Required bronchoscopy
3Infection signs and infiltration shadow on chest radiography
4Ventilation support >48 h
5Adult respiratory distress
6Required treatment
7Required drainage
8Required blood transfusion
9Required hemodialysis, postoperative serum concentration of creatinine >4 mg/dL or more than three times the preoperative value
Discharge information
| Date |
| Status upon hospital discharge (deada or alive or transfer to another hospital) |
| Status 30 days after surgery (dead or alive) |
| Redo-surgery |
aOutcome was classified as “in-hospital death” even if the patient died after transfer to another hospital
Cause of death
| Primary disease |
| Other malignancy |
| Cardiovascular related |
| Cerebrovascular related |
| Pneumonia |
| Interstitial pneumonia |
| Empyema/mediastinitis |
| Bronchopleural fistulae |
| Respiratory failure |
| Pulmonary emboli |
| Other (supplementary explanation) |
| Uncertain |
Fig. 3Internet-based audit system. An Internet-based audit system was developed to maintain the data quality of the NCD for chest surgery. Surgeons had to provide anonymous operative notes of patients selected randomly by the NCD and given to the JACS at the time of application for board certification for chest surgery. A committee authorized by the NCD and JACS could check the inter-rater reliability between these samples and Internet-based data from the NCD
Fig. 4Number of patients registered for chest surgery and for other fields of surgery of the NCD 2014 for each surgical procedure. Malignant neoplasm included lung cancer and metastatic lung tumor. Bulla-related procedures included bullectomy and volume reduction surgery
Fig. 5Comparison between the annual report by JATS and NCD 2014 shows the number of registrations to be almost identical for the selected thoracic diseases
Fig. 6Ratio of inter-rater agreement of operative data based on 563 operative notes. Agreement was >94 % which is acceptable, but will improve with better education and database management